Pages that link to "Q36873138"
Jump to navigation
Jump to search
The following pages link to Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial (Q36873138):
Displaying 50 items.
- QT interval and antidepressant use: a cross sectional study of electronic health records (Q24629713) (← links)
- Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure (Q26796378) (← links)
- Cardiovascular considerations in antidepressant therapy: an evidence-based review (Q27021843) (← links)
- Role of Heart and its Diseases in the Etiology of Depression According to Avicenna's Point of View and its Comparison with Views of Classic Medicine (Q28084482) (← links)
- The Protective Role of Positive Well-Being in Cardiovascular Disease: Review of Current Evidence, Mechanisms, and Clinical Implications (Q29048622) (← links)
- Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study (Q30838926) (← links)
- Position paper on the importance of psychosocial factors in cardiology: Update 2013 (Q33576193) (← links)
- Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE (Q33610031) (← links)
- Inflammatory depressive bowel diseases: the new era (Q33928789) (← links)
- Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: a systematic review (Q34087791) (← links)
- Depression and cardiovascular disease: an update on how course of illness may influence risk (Q34130495) (← links)
- Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients (Q34384552) (← links)
- Recognition of depression and anxiety and their association with quality of life, hospitalization and mortality in primary care patients with heart failure - study protocol of a longitudinal observation study (Q34464023) (← links)
- Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review (Q34544536) (← links)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib (Q34677347) (← links)
- Characteristics of Depression Remission and Its Relation With Cardiovascular Outcome Among Patients With Chronic Heart Failure (from the SADHART-CHF Study) (Q34777512) (← links)
- Screening and management of depression for adults with chronic diseases: an evidence-based analysis (Q35019551) (← links)
- Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial (Q35230653) (← links)
- Epidemiology and treatment of depression in patients with chronic medical illness (Q35237231) (← links)
- Depression is associated with cognitive dysfunction in older adults with heart failure (Q35614944) (← links)
- Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training (Q35629922) (← links)
- Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure (Q35634451) (← links)
- Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study (Q35763631) (← links)
- Depression as a Clinical Determinant of Dependence and Low Quality of Life in Elderly Patients with Cardiovascular Disease (Q35794546) (← links)
- A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality (Q35816629) (← links)
- Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND) (Q35856417) (← links)
- Treatment of affective disorders in cardiac disease (Q35899447) (← links)
- Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study (Q36048087) (← links)
- Depression in patients with cardiovascular disease. (Q36099872) (← links)
- Association between neutrophilic granulocyte percentage and depression in hospitalized patients with heart failure (Q36220880) (← links)
- Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study (Q36399638) (← links)
- Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial (Q36441748) (← links)
- Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial (Q36462172) (← links)
- Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). (Q36476538) (← links)
- Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial (Q36479731) (← links)
- Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain (Q36674169) (← links)
- Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION). (Q36720142) (← links)
- Early treatment of depressive symptoms and long-term survival after liver transplantation (Q36745462) (← links)
- Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial (Q36777112) (← links)
- Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes (Q36782608) (← links)
- Poor social support is associated with increases in depression but not anxiety over 2 years in heart failure outpatients (Q36788243) (← links)
- Depression and cardiac disease: epidemiology, mechanisms, and diagnosis (Q36802104) (← links)
- Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial (Q36987340) (← links)
- Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial (Q36998904) (← links)
- Association of depression and survival in patients with chronic heart failure over 12 Years (Q37063491) (← links)
- New frontiers in cardiovascular behavioral medicine: Comparative effectiveness of exercise and medication in treating depression (Q37111596) (← links)
- The Effect of Guided Web-Based Cognitive Behavioral Therapy on Patients With Depressive Symptoms and Heart Failure: A Pilot Randomized Controlled Trial (Q37350882) (← links)
- Diagnosis of Dilated Cardiomyopathy: Patient Reaction and Adaptation-Case Study and Review of the Literature. (Q37378339) (← links)
- Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature (Q37407146) (← links)
- Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial (Q37636086) (← links)